WallStreetZenWallStreetZen

NYSE: IQV
Iqvia Holdings Inc Stock

Overview
ForecastEarningsDividendOwnership
$231.77-3.71 (-1.58%)
Updated Apr 30, 2024
IQV Price
$231.77
Fair Value Price
N/A
Market Cap
$42.07B
52 Week Low
$167.42
52 Week High
$261.73
P/E
31.36x
P/B
6.88x
P/S
2.84x
PEG
1.04x
Dividend Yield
N/A
Revenue
$14.98B
Earnings
$1.36B
Gross Margin
35%
Operating Margin
14.22%
Profit Margin
9.1%
Debt to Equity
3.37
Operating Cash Flow
$2B
Beta
1.19
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A

IQV Overview

IQVIA Holdings Incorporated provides advanced analytics, technology solutions, and clinical research services to the life sciences sector in the U.S. and internationally. The company offers project management and clinical monitoring, clinical trial support, strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. IQVIA was founded in 1982 and is headquartered in Durham, NC.

Zen Score

–
Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IQV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IQV ($231.77) is trading above its intrinsic value of $118.60, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
IQV is good value based on its earnings relative to its share price (31.36x), compared to the US market average (40.82x)
P/E vs Market Valuation
IQV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more IQV due diligence checks available for Premium users.

Be the first to know about important IQV news, forecast changes, insider trades & much more!

IQV News

Valuation

IQV price to earnings (PE)

For valuing profitable companies with steady earnings
Company
31.36x
Industry
38.23x
Market
40.82x
IQV is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
IQV is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

IQV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
6.88x
Industry
4.16x
IQV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IQV price to earnings growth (PEG)

For valuing profitable companies with growth potential
IQV is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

IQV's financial health

Profit margin

Revenue
$3.9B
Net Income
$469.0M
Profit Margin
12.1%
IQV's Earnings (EBIT) of $2.13B... subscribe to Premium to read more.
Interest Coverage Financials
IQV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$26.7B
Liabilities
$20.6B
Debt to equity
3.37
IQV's short-term liabilities ($6.49B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IQV's long-term liabilities ($14.08B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IQV's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
IQV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$747.0M
Investing
-$212.0M
Financing
-$420.0M
IQV's operating cash flow ($2.15B)... subscribe to Premium to read more.
Debt Coverage Financials

IQV vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
IQV$42.07B-1.58%31.36x6.88x
IDXX$40.94B-2.49%48.45x27.58x
A$40.16B-1.83%32.47x6.49x
MTD$26.41B-2.03%34.06x-176.16x
ICLR$24.63B-2.06%35.89x2.61x
View Top Diagnostic & Research Stocks

Iqvia Holdings Stock FAQ

What is Iqvia Holdings's quote symbol?

(NYSE: IQV) Iqvia Holdings trades on the NYSE under the ticker symbol IQV. Iqvia Holdings stock quotes can also be displayed as NYSE: IQV.

If you're new to stock investing, here's how to buy Iqvia Holdings stock.

What is the 52 week high and low for Iqvia Holdings (NYSE: IQV)?

(NYSE: IQV) Iqvia Holdings's 52-week high was $261.73, and its 52-week low was $167.42. It is currently -11.45% from its 52-week high and 38.44% from its 52-week low.

How much is Iqvia Holdings stock worth today?

(NYSE: IQV) Iqvia Holdings currently has 181,500,000 outstanding shares. With Iqvia Holdings stock trading at $231.77 per share, the total value of Iqvia Holdings stock (market capitalization) is $42.07B.

Iqvia Holdings stock was originally listed at a price of $42.11 in May 9, 2013. If you had invested in Iqvia Holdings stock at $42.11, your return over the last 10 years would have been 450.39%, for an annualized return of 18.6% (not including any dividends or dividend reinvestments).

How much is Iqvia Holdings's stock price per share?

(NYSE: IQV) Iqvia Holdings stock price per share is $231.77 today (as of Apr 30, 2024).

What is Iqvia Holdings's Market Cap?

(NYSE: IQV) Iqvia Holdings's market cap is $42.07B, as of May 1, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Iqvia Holdings's market cap is calculated by multiplying IQV's current stock price of $231.77 by IQV's total outstanding shares of 181,500,000.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.